← Browse by Condition
Medical Condition

mycosis fungoides

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for mycosis fungoides sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — mycosis fungoides Clinical Trials

How many clinical trials are currently recruiting for mycosis fungoides?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for mycosis fungoides, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for mycosis fungoides?
mycosis fungoides research spans Phase 1 (1 trial), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a mycosis fungoides clinical trial?
Eligibility criteria for mycosis fungoides trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
1
Top Sponsors
Mayo Clinic 1 trial
M.D. Anderson Cancer Center 1 trial
Kyowa Kirin Co., Ltd. 1 trial

Recruiting Clinical Trials

NCT06508463 Phase 1
Recruiting
Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
Enrollment
21 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT05357794 Phase 2
Recruiting
Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides
Enrollment
30 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT07132567
Recruiting
Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance
Enrollment
15 pts
Location
South Korea
Sponsor
Kyowa Kirin Co., Ltd.
View Trial →

Related Conditions

peripheral t cell lymphoma (1) relapsed peripheral t cell lymphoma (1) peripheral t cell lymphoma not otherwise specified (1) anaplastic large cell lymphoma (1) relapsed anaplastic large cell lymphoma (1) relapsed mycosis fungoides (1) sezary syndrome (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology